4.5 Review

The current role of MRI for guiding active surveillance in prostate cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer

Carissa E. Chu et al.

Summary: Serial prostate magnetic resonance imaging in men with low-risk prostate cancer on active surveillance improves prognostic value and provides additional risk stratification. An increase in PI-RADS scores was associated with biopsy upgrade and definitive treatment. Validation in other cohorts is needed.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort

Francesco Giganti et al.

Summary: In patients on active surveillance for prostate cancer with multiple MRI scans, those without radiological progression according to the PRECISE score had a low likelihood of clinical progression, leading to the potential to avoid routine re-biopsy.

EUROPEAN RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance

Iztok Caglic et al.

Summary: The study evaluated the predictive value of the PRECISE scoring system in prostate cancer patients on active surveillance, showing good overall performance with high sensitivity, specificity, and negative predictive value. Prostate-specific antigen density, Likert lesion score, and index lesion size were significant baseline predictors of disease progression.

EUROPEAN RADIOLOGY (2021)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Review Urology & Nephrology

Advances in the selection of patients with prostate cancer for active surveillance

James L. Liu et al.

Summary: Accurate selection of low-risk prostate cancer patients for active surveillance is crucial, and new imaging methods and biomarkers can help reduce misclassification and predict disease progression.

NATURE REVIEWS UROLOGY (2021)

Review Urology & Nephrology

Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis

Pawel Rajwa et al.

Summary: The study evaluated the diagnostic estimates of serial prostate MRI for PCa progression during AS, suggesting that MRI alone is not accurate enough to reliably rule out or rule in prostate cancer progression. Other clinical factors and biomarkers are needed to tailor the intensity of follow-up biopsies.

EUROPEAN UROLOGY (2021)

Review Oncology

Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review

Dinul Hettiarachchi et al.

Summary: This systematic review evaluated the diagnostic performance of mp-MRI for disease progression in men on active surveillance for prostate cancer. The results suggest that prostate biopsies cannot be completely replaced by mp-MRI at this time.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Urology & Nephrology

Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance

Walter Hsiang et al.

Summary: The study found that progression on serial mpMRI is not associated with pathological upgrade in men with GG1 PCa on active surveillance. However, a high initial PI-RADS score on mpMRI is predictive of subsequent pathological progression. Both systematic and fusion biopsies are necessary to monitor progression during active surveillance.

EUROPEAN UROLOGY FOCUS (2021)

Article Medicine, General & Internal

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

Michael Ahdoot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Urology & Nephrology

Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists

Geoffrey A. Sonn et al.

EUROPEAN UROLOGY FOCUS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI

Yang Song et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)

Article Medicine, General & Internal

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

V Kasivisvanathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Artificial intelligence in radiology

Ahmed Hosny et al.

NATURE REVIEWS CANCER (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Detection of prostate cancer in multiparametric MRI using random forest with instance weighting

Nathan Lay et al.

JOURNAL OF MEDICAL IMAGING (2017)

Article Urology & Nephrology

Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value

Ely R. Felker et al.

JOURNAL OF UROLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists

Andrew B. Rosenkrantz et al.

RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI

Geert J. S. Litjens et al.

EUROPEAN RADIOLOGY (2015)

Article Medicine, General & Internal

Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

M. Minhaj Siddiqui et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology

Lars Boesen et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up

Soroush Rais-Bahrami et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2014)

Article Oncology

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

Jeffrey J. Tosoian et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)